Advertisement
Screener

CORCEPT THERAPEUTICS INC (CORT) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

CORCEPT THERAPEUTICS INC Cash Flow Breakdown

Cash flow breakdown shows where CORCEPT THERAPEUTICS INC's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $142.00M came in.
  • Fiscal year ended 2025-12-31: from investing, $69.76M came in.
  • Fiscal year ended 2025-12-31: from financing, $220.37M went out.
  • Fiscal year ended 2025-12-31: change in cash, $7.17M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backStaff share taxNew shares soldNot split outChange in cash
2025-12-31$142.00M$69.76M-$172.91M-$72.94M$15.87M$9.62M*-$7.17M
2024-12-31$198.29M-$177.60M-$15.66M-$22.30M$4.16M$5.46M*-$7.89M
2023-12-31$126.68M$90.91M$0.00-$9.11M$1.98M-$141.59M*$69.22M
2022-12-31$120.32M-$114.33M$0.00-$21.66M$990.00K$3.39M*-$11.29M
2021-12-31$167.89M$136.13M-$22.84M-$279.76M*$1.43M
2020-12-31$151.97M-$119.26M-$1.07M$13.28M*$44.92M
2019-12-31$136.12M-$117.83M-$30.98M$0.00-$6.09M$8.42M*-$10.36M
2018-12-31$115.67M-$90.77M-$23.66M$0.00$0.00$9.32M*$10.56M
2017-12-31$60.94M-$73.46M$0.00-$15.13M$7.18M-$20.47M
2016-12-31$18.39M-$194.00K$0.00-$14.78M$7.68M$11.10M
2015-12-31$3.13M-$17.00K-$9.21M$5.19M$17.09M*$16.19M
2014-12-31-$27.38M-$174.00K-$4.86M$1.78M-$30.63M
2013-12-31-$37.06M-$127.00K-$1.02M$55.00K-$38.16M
2012-12-31-$36.02M-$151.00K$46.10M$43.47M*$53.40M
2011-12-31-$27.40M-$25.00K$41.80M$682.00K*$15.06M
2010-12-31-$22.29M$23.00M*$711.00K
2009-12-31-$17.97M$3.59M$23.52M*$9.15M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backStaff share taxNew shares soldNot split outChange in cash
2026-06-30$33.54M*-$29.24M*$0.00*-$11.46M*$5.76M*$3.66M*
2026-03-31-$16.77M$4.54M$0.00-$5.76M$3.98M$2.54M*-$11.76M
2025-12-31$38.45M*-$11.84M*$0.00*-$36.54M*$2.86M*$2.46M*
2025-09-30$54.48M*$14.64M*-$42.46M*-$8.15M*$2.03M*$2.17M*
2025-06-30$44.30M*$70.13M*-$103.02M*-$12.43M*$9.23M*$3.27M*
2025-03-31$4.77M-$3.17M-$27.43M-$15.82M$1.74M$1.72M*-$37.85M
2024-12-31$60.06M*-$64.36M*$0.00*-$6.99M*$889.00K*$1.53M*
2024-09-30$73.29M*-$44.04M*-$11.71M*-$11.65M*$980.00K*$1.29M*
2024-06-30$41.19M*-$60.19M*-$3.48M*-$1.91M*$1.54M*
2024-03-31$23.76M-$9.01M-$476.00K*-$1.76M$749.00K$14.20M
2023-12-31$5.53M*$17.10M*$0.00*-$995.00K*$875.00K*
2023-09-30$52.91M*-$109.57M*$0.00*-$5.06M*$704.00K*
2023-06-30$42.29M*-$24.10M*$0.00*-$1.82M*$2.25M*-$146.19M*
2023-03-31$25.96M$207.47M$0.00-$1.23M*$0.00$233.61M
2022-12-31$33.39M*-$17.24M*$0.00*-$846.00K*
2022-09-30$33.65M*-$4.79M*$0.00*-$15.63M*$1.66M*
2022-06-30$18.04M*-$41.80M*$0.00*-$3.31M*$550.00K*
2022-03-31$35.25M-$50.50M$0.00-$1.89M$1.38M*-$15.76M
2021-12-31$49.43M*$140.47M*-$2.52M*-$204.45M*
2021-09-30$48.70M*-$25.80M*-$25.77M*$2.13M*
2021-06-30$44.34M*$24.74M*-$29.17M*$3.14M*
2021-03-31$25.42M-$3.28M-$33.54M-$16.44M$4.04M*-$23.81M
2020-12-31$35.07M*$11.22M*-$9.67M*-$977.00K*
2020-09-30$30.44M*-$64.27M*$0.00*-$27.00K*$5.89M*
2020-06-30$53.19M*-$85.94M*$0.00*-$100.00K$6.90M*
2020-03-31$33.27M$19.73M-$275.00K$0.00$53.21M
2019-12-31$48.45M*-$61.99M*$0.00*-$1.92M*
2019-09-30$38.43M*-$54.32M*$0.00*$0.00*$2.70M*
2019-06-30$25.55M*-$1.16M*-$17.42M*$0.00*$1.51M*
2019-03-31$23.68M-$367.00K-$13.55M-$4.17M$2.44M*$8.03M
2018-12-31$21.52M*-$1.76M*-$14.75M*$0.00*$0.00*$2.72M*
2018-09-30$44.51M*-$33.51M*-$8.90M*$0.00*$0.00*$634.00K*
2018-06-30$15.21M*-$21.21M*$0.00*$0.00*$0.00*$4.04M*
2018-03-31$34.43M-$34.29M$0.00$0.00$0.00$1.92M*$2.06M
2017-12-31$24.88M*-$27.45M*$0.00*$0.00*$2.57M*$2.00K*
2017-09-30$10.93M*-$11.65M*-$4.61M*$2.77M*-$2.56M*
2017-06-30$15.57M*-$14.95M*-$5.69M*$718.00K*-$4.35M*
2017-03-31$9.56M-$19.41M-$4.83M$1.12M*-$13.56M
2016-12-31$4.57M*-$75.00K*-$4.43M*$3.61M*$3.67M*
2016-09-30$8.94M*-$90.00K*-$4.04M*$1.27M*$6.08M*
2016-06-30$1.59M*-$7.00K*-$3.27M*$2.73M*$1.04M*
2016-03-31$3.30M-$22.00K-$3.04M$309.00K
2015-12-31$4.16M*$17.00K*-$2.76M*$3.98M*
2015-09-30$883.00K*$0.00*-$2.49M*$1.01M*-$598.00K*
2015-06-30-$139.00K*$0.00*-$2.09M*$1.32M*-$905.00K*
2015-03-31-$1.78M-$34.00K-$1.86M$17.38M*$13.71M
2014-12-31-$1.40M*$0.00*-$1.57M*-$2.53M*
2014-09-30-$5.93M*-$16.00K*-$1.28M*-$7.19M*
2014-06-30-$8.98M*-$48.00K*-$1.02M*-$9.64M*
2014-03-31-$11.06M-$110.00K-$995.00K*-$11.26M
2013-12-31-$7.67M*-$40.00K*-$647.00K*-$8.30M*
2013-09-30-$8.60M*-$65.00K*-$9.04M*
2013-06-30-$9.24M*-$4.00K*-$9.24M*
2013-03-31-$11.55M-$18.00K-$11.57M
2012-12-31-$8.74M*-$58.00K*-$8.60M*
2012-09-30-$9.23M*-$52.00K*$76.01M*$66.73M*
2012-06-30-$7.89M*-$34.00K*-$7.73M*
2012-03-31-$10.16M-$7.00K$13.16M*$2.99M
2011-12-31-$6.29M*-$6.27M*
2011-09-30-$6.60M*-$6.32M*
2011-06-30-$7.21M*-$6.97M*
2011-03-31-$7.29M$41.92M*$34.62M
2010-12-31-$5.46M*$1.06M*-$4.40M*
2010-09-30-$6.43M*-$6.41M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52